Bogomolovas J, Simon B, Sattler M, Stier G, (2009) Screening of fusion partners for high yield expression and purification of bioactive viscotoxins. Protein Expr Purif, 64:16–23.
Cheng SH, Tu Y, Zhang S (2013) FOXM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression. PLoS ONE 8: 1-10.
Cheng Y, Zhao J, Qiao W, Chen K (2014) Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates. Am. J. Nucl Med Mol 4: 385-405.
Chetty C, Bhoopathi P, Rao JS, Lakka S, (2009) Inhibition of Matrix Metalloproteinase-2 Enhances Radiosensitivity by Abrogating Radiation-induced FoxM1-mediated G2/M Arrest in A549 Lung Cancer Cells. Int J Cancer 124(10): 2468–2477.
Dai B, Kang SH, Gong W, et al., (2007) Aberrant FOXM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26: 6212–6219.
Dardevet L, Rani D, Abd El Aziz T, et al., (2015) Chlorotoxin: A Helpful Natural Scorpion Peptide to Diagnose Glioma and Fight Tumor Invasion. Toxins 7: 1079-1101.
Dastpeyman M, Giacomin P, Wilson D, et al, (2019) A C-Terminal Fragment of Chlorotoxin Retains Bioactivity and Inhibits Cell Migration. Front Pharmacol 10 (250): 1- 10.
Deshane J, Garner CC, Sontheimer H, (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278: 4135–44.
El-Ghlban S, Kasai T, Shigehiro T, et al, (2014) Chlorotoxin-Fc Fusion Inhibits Release of MMP-2 from Pancreatic Cancer Cells. BioMed Res Int 1: 1-10.
Esposito D, Chatterjee DK, (2006) Enhancement of soluble protein expression through the use of fusion tags. Currt Opin Biotechnol, 17:353–358
Farsani FM, Ayat H, Ahadi AM, (2015) Molecular Modeling and Docking Studies on the First Chlorotoxin-Like Peptide from Iranian Scorpion Mesobuthus eupeus (Meict) and SNP Variants of Matrix Methaloproteinase-2 (MMP-2). Iranain J Toxicol 9: 1368-1376.
Fau YJ, Yin LT, Liang AH, et al, (2007) Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett 412: 62–67.
Fu YJ, An N, Chan KG, et al, (2011) A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnol Lett 33: 1309–1317.
Halasi M, Gartel AL, (2013) Targeting FOXM1 in cancer. Biochem Pharmacol 85: 644–652.
Ilkhanizade S, Ayat H, Ahadi AM, Pirali K, (2011) Sequencing and comparative-bioinformatic analysis of chlorotoxin-like peptide from Iranian scorpion Mesobuthus eupeus. J SKU Med Sci. 13: 27-36.
LaVallie ER, Lu Z, Diblasio-Smith EA, Collins-Racie LA, McCoy JM (2000) Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli. Methods Enzymol 326: 322–340.
Liang J, Lv X, Lu C, et al, (2020) Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas, BMC cancer 20: 35, 1-7.
Liao G, Li X, Zeng S, Liu C, Yang S, Yang L, Hu C, Bai J, (2018) Regulation of the master regulator FOXM1 in cancer. J Cell Commun Signal 16:57, 1-15.
Lyukmanova EN, Shulepko MA, Shenkarev ZO, Dolgikh DA, Kirpichnikov MP, (2010) In vitro production of three-finger neurotoxins from snake venoms, a disulfide rich proteins. Problems and their solutions (Review). Russ J Bioorg Chem, 36:137–145.
Kesavan K, Ratliff J, Johnson EW, et al, (2009) Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem 285: 4366–4374.
Othman H, Wieninger SA, ElAyeb M, et al, (2017) In silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion. J Biomol Struct Dyn 35: 2815–2829. doi: 10.1080/07391102.2016.1231633
Pullen NA, Pickford AR, Perry MM, et al, (2018) Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary. Metalloproteinases In Med, 5: 13-30
Rezaei L, Ayat H, Ahadi AM, (2021) Design and construction of pET32b(+) Rh expression vector based on pET system to facilitate purification. J cell mol res. 34: (2), 169-181.
Rjeibi K, Mabrouk H, Mosrati C, et al, (2011) Purification, synthesis and characterization of AaCTX, the first chlorotoxin-like peptide from Androctonus australis scorpion venom, Peptides 32: 656–663.
Roomi MW, Ivanov V, Kalinovsky T, et al, (2007) Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture. Med Oncol 24: 231–8.
Sharma MC, (2019) Annexin A2 (ANNEXIN A2): An emerging biomarker and potential therapeutic target for aggressive cancers, Int J Cancer 144: 2074-2081.
Sun N, Zhao L, Qiao W, et al, (2017) BmK CT and I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2, Mol Med Rep 15: 2703-2708.
Turner KL, Sontheimer H (2014) Cl- and K+ channels and their role in primary brain tumour biology, Philos Trans R Soc B 369: 1-9.
Wang CY, Lin CF (2014) Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer Development Dis Markers 1-10.
Xu T, Fan Z, Li W, et al. (2016). Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci Rep 25: 1-14.
Zhai H, Acharya S, Gravanis I, et al. (2011) Annexin A2 Promotes Glioma Cell Invasion and Tumor Progression. J Neurosci. 31(40): 14346-60.
Zhang X, LV Q, Huang Y, et al. (2017) Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma. J Exp Clin Cancer Res 36: 1-18.
Zhao P, Zhang W, Tang J, et al. (2010) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101: 387–395.